FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37653038> ?p ?o ?g. }

• Q37653038 description "article científic" @default.
• Q37653038 description "article scientifique" @default.
• Q37653038 description "articolo scientifico" @default.
• Q37653038 description "artigo científico" @default.
• Q37653038 description "artículu científicu espublizáu en 2013" @default.
• Q37653038 description "bilimsel makale" @default.
• Q37653038 description "scientific article published on 20 September 2013" @default.
• Q37653038 description "vedecký článok" @default.
• Q37653038 description "vetenskaplig artikel" @default.
• Q37653038 description "videnskabelig artikel" @default.
• Q37653038 description "vědecký článek" @default.
• Q37653038 description "wetenschappelijk artikel" @default.
• Q37653038 description "wissenschaftlicher Artikel" @default.
• Q37653038 description "наукова стаття, опублікована у вересні 2013" @default.
• Q37653038 description "научни чланак" @default.
• Q37653038 description "مقالة علمية نشرت في 20 سبتمبر 2013" @default.
• Q37653038 name "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 name "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 name "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based" @default.
• Q37653038 type Item @default.
• Q37653038 label "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 label "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 label "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based" @default.
• Q37653038 prefLabel "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 prefLabel "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 prefLabel "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based" @default.
• Q37653038 P1433 Q37653038-E5467A16-3F6E-44B7-B15D-E0C8C5A8769F @default.
• Q37653038 P1476 Q37653038-0250B097-CB97-4AD6-9E49-01EAED07440F @default.
• Q37653038 P2093 Q37653038-03C81158-3C13-4BBB-A6E9-3BDB8FC6F303 @default.
• Q37653038 P2093 Q37653038-46979928-124B-4741-AC12-83335F9BB8C0 @default.
• Q37653038 P2093 Q37653038-516EC1CD-1B0C-4F1C-8C02-F855D0605631 @default.
• Q37653038 P2093 Q37653038-B5676EAE-13AF-4396-B79F-D3E2EAD80ACB @default.
• Q37653038 P2860 Q37653038-01271012-57D4-4D0E-A490-9AE05A7C718E @default.
• Q37653038 P2860 Q37653038-01FDFA87-C950-4C3B-9A03-92DDAB87478B @default.
• Q37653038 P2860 Q37653038-04F24179-115E-49BD-B989-AD9F3E19BA85 @default.
• Q37653038 P2860 Q37653038-11CA91A4-DD8C-43F7-9F43-64309D234BC7 @default.
• Q37653038 P2860 Q37653038-13E82376-A2B2-431A-856D-F24699F7B33A @default.
• Q37653038 P2860 Q37653038-147D64F0-2C30-4DC8-8413-1F2958ECAAAF @default.
• Q37653038 P2860 Q37653038-171A70F8-1BD5-4356-AEDC-A84CD146EA46 @default.
• Q37653038 P2860 Q37653038-1879942A-CA08-46D1-9EDA-F61B0FC67756 @default.
• Q37653038 P2860 Q37653038-23726331-3127-497F-BFCE-D77D1ACC55B4 @default.
• Q37653038 P2860 Q37653038-280AC438-EAF4-4C74-A8E5-F3B507E40038 @default.
• Q37653038 P2860 Q37653038-391908A2-1C43-4DFE-ADCC-1D4909063AC4 @default.
• Q37653038 P2860 Q37653038-3BC7420B-42AE-4119-8335-8047AEE42B17 @default.
• Q37653038 P2860 Q37653038-3E631C02-D9D3-40F1-BADE-2D7C93E746D5 @default.
• Q37653038 P2860 Q37653038-3F58EFBA-D0DC-4126-A033-C87D631C43F7 @default.
• Q37653038 P2860 Q37653038-40811600-E7CA-4DCA-BCEA-FDFD1FD8928F @default.
• Q37653038 P2860 Q37653038-41B9E3BD-627E-484B-8687-E58C53B1B3BA @default.
• Q37653038 P2860 Q37653038-41CCF112-05E1-41A2-96B5-EBC50B9F3285 @default.
• Q37653038 P2860 Q37653038-42D1CD7C-D91A-4B90-BD5D-A8D9BA7AE72D @default.
• Q37653038 P2860 Q37653038-4B3F0CCC-4800-40A7-8B36-FEF3A3AB9314 @default.
• Q37653038 P2860 Q37653038-546148E3-B03D-4432-B0EE-867F097585CF @default.
• Q37653038 P2860 Q37653038-5BF73113-54A3-4470-8F2E-ED9DF18F63DE @default.
• Q37653038 P2860 Q37653038-6C2308FD-1C65-4D91-A6C9-6CE50BE5DFF8 @default.
• Q37653038 P2860 Q37653038-7AD804E4-61CD-4AB7-A528-A6D967CC3768 @default.
• Q37653038 P2860 Q37653038-800431A0-9749-479E-BE58-4F102391EE4D @default.
• Q37653038 P2860 Q37653038-9CB2C979-4452-4847-B458-CF207121DEF4 @default.
• Q37653038 P2860 Q37653038-A43B6661-860A-4C6F-B0B1-5607AFD0C6E7 @default.
• Q37653038 P2860 Q37653038-A511554E-C0F6-4FA9-89AE-2B14C184AC82 @default.
• Q37653038 P2860 Q37653038-AB5CC637-3178-412F-8D67-44CB494E59C3 @default.
• Q37653038 P2860 Q37653038-AEC1B6BA-7257-4042-AF65-4B825618223F @default.
• Q37653038 P2860 Q37653038-B4D67CDD-C114-4E8C-B6A4-2E58416AB67E @default.
• Q37653038 P2860 Q37653038-C2A2BDDB-D7C7-4368-8CCF-C0D3634631CB @default.
• Q37653038 P2860 Q37653038-C70C046E-2BF1-46BC-BBDD-9307F8F64159 @default.
• Q37653038 P2860 Q37653038-CC80036D-86EA-4604-9A3D-B5985EBEA7FA @default.
• Q37653038 P2860 Q37653038-D627A65E-0818-4F6D-883E-7B879DB865AB @default.
• Q37653038 P2860 Q37653038-D7230756-0E9A-4D2A-A186-6777026D82B3 @default.
• Q37653038 P2860 Q37653038-E1DB6D4D-E9CC-4AAE-AD90-FA49CD64222E @default.
• Q37653038 P2860 Q37653038-EB04B6AC-7142-46B4-B5BF-C2A5E1059545 @default.
• Q37653038 P2860 Q37653038-F4BBDB0F-52A2-442F-8E2B-5F0ECE655527 @default.
• Q37653038 P2860 Q37653038-F79C55B9-9CBF-40B1-971B-E9E4643F70CF @default.
• Q37653038 P2860 Q37653038-FE2A4D5A-6EB3-4D05-B5FD-8F3C21FB088C @default.
• Q37653038 P304 Q37653038-F6DFEEB5-A141-47EB-A6F4-454734EE09E5 @default.
• Q37653038 P31 Q37653038-F2711B7A-4DD5-4108-BABA-D8CC5805871F @default.
• Q37653038 P356 Q37653038-39BA0768-B929-4B1F-862C-D9C3926D704F @default.
• Q37653038 P433 Q37653038-FB4CE615-737F-46DA-BBF4-EB35E4824F7F @default.
• Q37653038 P478 Q37653038-89C67839-B455-4AB8-B647-0968039A1C1F @default.
• Q37653038 P577 Q37653038-49AE247A-3EE2-4982-9C13-B6DCF3294E50 @default.
• Q37653038 P698 Q37653038-A1F9D599-231D-415B-9336-B8854D13FA69 @default.
• Q37653038 P921 Q37653038-48583EAC-3F15-409D-B1C1-D72760A607FC @default.
• Q37653038 P921 Q37653038-DAC6272B-3580-4DE5-B76E-80A4375A3C4C @default.
• Q37653038 P932 Q37653038-1D3E2DED-CFE2-4353-8BAE-C6AEE600D450 @default.
• Q37653038 P356 DTA.1534 @default.
• Q37653038 P698 24115758 @default.
• Q37653038 P1433 Q3040088 @default.
• Q37653038 P1476 "Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases" @default.
• Q37653038 P2093 "Daniel W Armstrong" @default.
• Q37653038 P2093 "Edra Dodbiba" @default.
• Q37653038 P2093 "Nilusha L T Padivitage" @default.
• Q37653038 P2093 "Zachary S Breitbach" @default.
• Q37653038 P2860 Q22252340 @default.
• Q37653038 P2860 Q24657966 @default.
• Q37653038 P2860 Q28235275 @default.
• Q37653038 P2860 Q28290646 @default.
• Q37653038 P2860 Q33299237 @default.
• Q37653038 P2860 Q35006123 @default.
• Q37653038 P2860 Q39881489 @default.
• Q37653038 P2860 Q43012698 @default.
• Q37653038 P2860 Q43246712 @default.
• Q37653038 P2860 Q43778439 @default.

• next